CTRI/2010/091/002939招募中3 期
A prospective, controlled, randomized, open, comparative, parallel, 2 - arm study to evaluate the efficacy and safety of FDC tablet of Aceclofenac 200 mg and Thiocolchicoside 16 mg SR versus FDC tablet of Aceclofenac 100 mg and Thiocolchicoside 8 mg IR in patients suffering from painful muscle spasms associated with musculoskeletal systems.
Themis Medicare Limited Udyog Nagar S V Road Goregaon West Mumbai0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients of either sex in the age group between 18 to 70 years.
- •2. Patients painful muscle spasms and contractions associated with cervical and lumbar spondylosis, rheumatoid arthritis, osteoarthritis, blunt superficial trauma, low back pain.
- •3. Subjects who provide a written informed consent to abide by the study requirements.
排除标准
- •1. Patients with painful muscle spasms associated with musculoskeletal systems, who need parenteral therapy / surgery / hospital admission for management.
- •2. Patients treated with any other oral / parenteral muscle relaxants, analgesics (NSAIDS & Opioids) medications within 1 week prior to the study.
- •3. Patients suffering from organic neurological disorders (Upper motor neuron disorders, cerebral palsy, pyramid tract injury, multiple sclerosis, cerebrovascular events, myelopathy, encephalomyelitis, etc), peripheral vascular diseases (arteriosclerosis obliterans, diabetic angiopathy, thrombangiitis obliterans, Raynaud's disease, diffuse scleroderma) as well as syndromes developing on the basis of impaired vascular innervation (acrocyanosis, dysbasia angioneurotica intermittent); Little's diseases and other encephalopathies accompanied by dystonia.
- •4. Patients suffering from myasthenia gravis or myopathies with muscle weakness as the prominent symptom.
- •5. Patients with known hypersensitivity to any of the ingredients of the test / comparator formulation.
- •6. Patients with severe cardiac, hepatic, gastrointestinal, renal, pulmonary and skin diseases.
- •7. Pregnant and lactating females.
- •8. Simultaneous participation in another clinical study.
研究者
相似试验
已完成
3 期
A clinical trial to study the effects of two drugs, Tolperisone and Diclofenac in patients suffering from acute muscle spasmsCTRI/2010/091/006069Themis Medicare Limited200
招募中
3 期
A clinical trial to study the efficacy and safety of FDC tablet containing Tolperisone 150 mg and Etodolac 200 mgCTRI/2010/091/001032Themis Medicare Limited200
进行中(未招募)
不适用
A prospective, randomized, verum controlled, open label, parallel group multi-center phase III clinical trial to demonstrate the superiority of 500 or 250 mg Aspirin® i.v. (BAY 81-8781) treatment versus 300 mg Aspirin® N tablets p.o. (BAY e4465A) in patients with Acute Coronary Syndrome, measured by time dependent thromboxane inhibition - ACUTE: Intravenous Aspirin in the Treatment of ACUTe Coronary SyndromEAcute coronary syndrome (ACS)MedDRA version: 14.1Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disordersEUCTR2007-005163-94-DEBayer HealthCare AG264
已完成
2 期
A comparative study of two pain relief techniques - An injection at the back with morphine(drug for pain relief) versus an abdominal wall injection for donor nephrectomy(donor kidney removal) surgeriesCTRI/2016/07/007110All India Institute of Medical Sciences60
已完成
不适用
CLBS12-P01Patients with critical limb ischemia (CLI) due to arteriosclerosis obliterans (ASO) and patients with CLI due to Buerger's Disease (BD)JPRN-jRCT1080223694EPS Corporation (Global Sponsor: Caladrius Biosciences, Inc.)35
